Grand Pharmaceutical Group Limited (FRA:MX6A)

Market Cap	1.78B -44.0%
Revenue (ttm)	1.39B +5.9%
Net Income	123.81M -47.3%
EPS	0.04 -47.3%
Shares Out	n/a
PE Ratio	13.54
Forward PE	8.65
Dividend	0.02 (3.83%)
Ex-Dividend Date	Jun 12, 2026

Volume	100
Open	0.4860
Previous Close	0.4760
Day's Range	0.4860 - 0.4880
52-Week Range	0.4740 - 0.9550
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About FRA:MX6A

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 12,326
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MX6A

Financial Performance

In 2025, FRA:MX6A's revenue was 12.28 billion, an increase of 5.48% compared to the previous year's 11.64 billion. Earnings were 1.24 billion, a decrease of -49.73%.

Financial numbers in HKD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error